Recombinant Human GPC2 Protein(HEK293)，His

GPC2 (Glypican-2) is a heparan sulfate proteoglycan that plays a crucial role in various developmental processes and has been implicated in several types of cancer. It is predominantly expressed in the nervous system and is known to influence cell signaling pathways, particularly in the context of neurodevelopment and tumor biology. Recent studies have highlighted GPC2 as a potential oncofetal antigen, which is overexpressed in certain tumors, including neuroblastoma, making it a target of interest for immunotherapeutic strategies. The development of GPC2 recombinant proteins is essential for advancing research into its biological functions and therapeutic applications. By producing these recombinant proteins, scientists can investigate GPC2's interactions with other molecules and its role in tumor progression. Additionally, these proteins can be utilized in the design of monoclonal antibodies or other immune-based therapies aimed at targeting and eliminating GPC2-expressing tumor cells. Understanding the molecular mechanisms underpinning GPC2's activity may open new avenues for cancer treatment and provide insights into its involvement in neurological disorders. This research is pivotal for elucidating the broader implications of GPC2 in both health and disease, with the ultimate goal of translating this knowledge into effective therapeutic options for patients.